Pangenomic Health Inc. (CSE:NARA)
0.170
0.00 (0.00%)
Feb 11, 2025, 4:00 PM EST
Pangenomic Health Statistics
Total Valuation
CSE:NARA has a market cap or net worth of CAD 1.09 million. The enterprise value is 1.06 million.
Market Cap | 1.09M |
Enterprise Value | 1.06M |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:NARA has 6.40 million shares outstanding. The number of shares has increased by 104.41% in one year.
Current Share Class | n/a |
Shares Outstanding | 6.40M |
Shares Change (YoY) | +104.41% |
Shares Change (QoQ) | +14.36% |
Owned by Insiders (%) | 39.63% |
Owned by Institutions (%) | n/a |
Float | 3.75M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.30 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
Current Ratio | 0.04 |
Quick Ratio | 0.04 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -20.89 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -598.23% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 67.41% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.33% in the last 52 weeks. The beta is -1.65, so CSE:NARA's price volatility has been lower than the market average.
Beta (5Y) | -1.65 |
52-Week Price Change | -77.33% |
50-Day Moving Average | 0.18 |
200-Day Moving Average | 0.33 |
Relative Strength Index (RSI) | 38.46 |
Average Volume (20 Days) | 16,821 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | -256,938 |
Operating Income | -1.11M |
Pretax Income | -3.51M |
Net Income | -3.51M |
EBITDA | -1.10M |
EBIT | -1.11M |
Earnings Per Share (EPS) | -0.92 |
Balance Sheet
Cash & Cash Equivalents | 29,256 |
Total Debt | n/a |
Net Cash | 29,256 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | -1.64M |
Book Value Per Share | -0.26 |
Working Capital | -1.65M |
Cash Flow
Operating Cash Flow | -369,793 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:NARA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -104.41% |
Shareholder Yield | -104.41% |
Earnings Yield | -322.74% |
FCF Yield | n/a |
Stock Splits
The last stock split was on November 14, 2024. It was a reverse split with a ratio of 0.2.
Last Split Date | Nov 14, 2024 |
Split Type | Reverse |
Split Ratio | 0.2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |